Prevention of Pain on Propofol Injection: A Comparison of Pretreatment with 5-Hydroxytryptamine 3 Antagonists Granisetron, Ondansetron, and Ramosetron
Annals of African Medicine · 2026
DOI: 10.4103/aam.aam_360_25 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of African Medicine, 2026. Verfasst von Srishti Kindo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India. Hauptthemen laut MEDLINE: Ondansetron, Granisetron, Benzimidazoles, Propofol. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims: Propofol is commonly used for the induction and maintenance of anesthesia. However, approximately 28%–90% of patients experience pain during injection. In this study, we compared the effectiveness of ondansetron, ramosetron, and granisetron, the three common 5-hydroxytryptamine 3 receptor antagonists in reducing the incidence and severity of propofol-induced pain (PIP).
Methods
This study included 120 adult patients (18–65 years old) scheduled for elective laparoscopic cholecystectomy under general anesthesia. Patients were randomly assigned to four groups ( n = 30 for each group). Granisetron (2 mg) was administered to Group G, ramosetron (0.3 mg) to Group R, ondansetron (4 mg) to Group O, and normal saline to Group N. Venous circulation was occluded by a rubber tourniquet to retain the drug in the vein and prevent its spread in circulation. Pain was assessed at 0, 5, 10, 15, and 20 s using a four-point verbal rating scale (VRS). The Kruskal–Wallis, Chi-square, Friedman tests, and generalized estimating equations were used to analyze the data.
Results
Groups O, R, and G demonstrated significantly reduced pain compared to group N at all-time points ( P < 0.001). Granisetron (Group G) was the most effective, with a mean VRS of 0.00 at 20 s. PIP incidence was 100% in Group N, compared to 80%, 70%, and 26.7% in Groups O, R, and G, respectively (χ² =40.443, P < 0.001).
Conclusion
Granisetron is the most effective in reducing PIP, though ondansetron and ramosetron also offer significant pain relief.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesia, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
- Department of Cardiac Anaesthesia, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
- Department of Superspeciality Anaesthesia, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
- Medeor Hospital, Dubai, UAE.
- Department of Pathology, Gandhi Nagar Hospital, Central Coalfields Ltd., Ranchi, Jharkhand, India.
- Department of Critical Care Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
Zitieren
APA
Kindo, S., Sinha, N., Singh, D., Kumar, S., Priye, S., Saran, K., & Prakash, J. (2026). Prevention of Pain on Propofol Injection: A Comparison of Pretreatment with 5-Hydroxytryptamine 3 Antagonists Granisetron, Ondansetron, and Ramosetron. Annals of African Medicine. https://doi.org/10.4103/aam.aam_360_25
Vancouver
Kindo S, Sinha N, Singh D, Kumar S, Priye S, Saran K, et al. Prevention of Pain on Propofol Injection: A Comparison of Pretreatment with 5-Hydroxytryptamine 3 Antagonists Granisetron, Ondansetron, and Ramosetron. Annals of African Medicine. 2026. doi:10.4103/aam.aam_360_25
BibTeX
@article{Kindo2026,
author = {Kindo, Srishti and Sinha, Nitesh and Singh, Dipali and Kumar, Subodh and Priye, Shio and Saran, Khushboo and Prakash, Jay},
title = {Prevention of Pain on Propofol Injection: A Comparison of Pretreatment with 5-Hydroxytryptamine 3 Antagonists Granisetron, Ondansetron, and Ramosetron},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_360_25}
}
EUVIMED